chrisvoncsefalvay/vaers-outcomes huggingface dataset:
headache; nauseated; achy; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age (reported as 73 [unit unspecified]) received her first dose of bnt162b2 (BNT162B2 reported as Pfizer-Biontech Covid-19 Vaccine; unknown lot number and expiration date), via an unspecified route of administration on 16Jan2021 at a single dose for covid-19 immunization. Medical history included SARS-Cov-2 from 09Dec2020 to an unknown date and IBS (irritable bowel syndrome). The patient's concomitant medications were not reported. The patient reported that she had the injection which was basically painless. The patient reported that she had headache, nauseated and achy on an unspecified date in Jan2021. The patient underwent lab tests and procedures which included blood pressure was fine, oxygen saturation (pulse ox) was fine, and weight was 99 lbs., all on an unspecified date. The outcome of the events was unknown.   The following information on the batch/lot number has been requested.
Initial report received from a Registered Nurse in the USA on 16/May/2006. A 37-year-old female patient with an allergy to latex developed pain and swelling at the injection site and the left side of her neck the day she received the intramuscular injection of Decavac, lot number U1618CA (expiry date 23/May/2007) in the left deltoid on 09/May/ 2006. She also received a TB skin test, lot number reported as 26902, manufacturer not reported in the right forearm on 08/May/2006. Per reporter the patient had no illness at the time of vaccination. The patient had difficulty raising her left arm and had pain down her arm to the 4th and 5th digits. On 10/May/2006 the patient was seen in the emergency department and given Lyrtacl and Toradol. Per reporter, the patient recovered.
Client received shot in the AM of 8/7/20. Client became tired as day went on and was super tired by the evening of the 7th. Client has tinnitus and that was exacerbated and became very loud. The client started a rash that started across her lower back and went to her upper back. She had chills the evening of the 7th but did not take her temperature. Rash was itchy on Saturday and she had small areas on her leg with a rash. She took a bath on Saturday with baking soda and oils that gave her some relief from the itch. The itching was better on Sunday and client developed a headache on Sunday evening. The headache is just dull today, but client feels a little "woozie". Client says she kind of has a cough today., and still is itchy to the rash areas. The client said her tinnitus is not as loud today. Client went to work but I encouraged her to go home and rest. She asked if she should call the clinic and be seen. I encouraged her to call and tell them her symptoms and see what their advice is.
The week before I had tingling sensation on my face and hot. Two days later I felt the tingling on my face again. I decided to lay on the couch. Then the tingling went to the back of my neck. My chest started to feel weird, and I started to have trouble breathing. My husband called the ambulance. My face was numb, and my hands were cramping. I got put on oxygen right away in the ambulance. I was on oxygen for 36 hours and I was admitted. My blood pressure was also high. My hands were numb for 4-5 hours. They did bloodwork around the clock. My electrolytes were extremely low, and my calcium and potassium were as well. They investigated my blood pressure medication to see if that was causing my problems. They also did a COVID test, and it came back negative. They are still trying to figure out why I have high blood pressure. They changed my medication to Amlodipine. I still do not feel 100 percent.
Breakthrough COVID: I was told that I had the flu. Then, they called and told me I also had COVID. The doctor wanted to see me that day in the parking lot. I went and he did more testing. He gave me medication for the flu. He wanted to see me back every day in the parking lot. On the 3rd day, he sent me to the hospital for the monoclonal antibodies. I was at the hospital for about 6 hours while they did that and about 3 or 4 weeks later, I started feeling better. It seems like my health is real my immune system seems to be really down because after that, 2 months later, I got pneumonia.
1:00 pm- muscle pain; 5:00 pm-muscle pain and headache;  10:00 pm- pain on all my body; 11:00 pm to 4:00 am- body pain, chills and fever. Treat myself with ice pack, lots of fluids, Advil and  rest.
abdominal pain comes and goes; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 33 year-old male patient received bnt162b2 (COMIRNATY), administration date 26Sep2021 (Batch/Lot number: unknown) at the age of 33 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ABDOMINAL PAIN (non-serious) with onset Sep2021, outcome "not recovered", described as "abdominal pain comes and goes".  Additional information: Caller received first dose of product 26Sep2021. Caller was reported intermittent abdominal pain comes and goes. He was asking if he should go to the emergency room or if it's a reported adverse event. States him and his son had cases of it and saw it was was reported with the J & J. Asked if it was standard.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
The patient turned pale, felt tingling all over, pupil dilated and was blurring over. PR = 80 / mier Bp = 90/60.
lymphadenopathy; Injection site pain; This is a spontaneous report received from non-contactable reporter(s) (Consumer or other non-healthcare professional) from a sales representative. The reporter is the patient. A patient (no qualifiers provided) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown (booster), single (Batch/Lot number: unknown), in arm for covid-19 immunisation. The patient relevant medical history was not reported. Concomitant medication(s) included: FLU VACCINE VII as dose number unknown, single. Vaccination history included: Covid-19 vaccine (Primary Immunization series completed, Manufacturer unknown) for COVID-19 immunization. The following information was reported: LYMPHADENOPATHY (non-serious), outcome "unknown", VACCINATION SITE PAIN (non-serious), outcome "unknown", described as "Injection site pain".  Additional information: Patient had no underlying conditions. Patient received concomitant flu vaccine in same arm. Event took place after use of COVID-19 bivalent booster.  No follow-up attempts are possible, information about lot/batch number cannot be obtained. No further information is expected.
Swelling, fluid, very red, hot to touch. This was few inches below injection site extending to only to elbow.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 68-year-old female patient (not pregnant) received BNT162b2 (BNT162B2 NOS), on 18Oct2022 at 14:00 as dose number unknown, single (Batch/Lot number: unknown) at the age of 67 years, in left arm for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2023, outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: Patient was treated with Paxlovid from 13May2023 to 18May2023.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Day after vaccine administration, developed body aches and low fever. Mild to moderate headache. Injection site in right arm feels swollen and tender.
This spontaneous report was received from a licensed vocational nurse (LVN) refers to unspecified patients of an unknown age and gender. The patient's concurrent conditions and medical history were not provided. on an unknown date, the patients were vaccinated with a dose of oral, ROTATEQ, (lot # K024700, expiration date 30-JUL-2016 and Lot No: L008051, expiration date 17-NOV-2016)(dose was not provided). The licensed vocational nurse (LVN) reported that on multiple unspecified dates, multiple unspecified patients were administered improperly stored oral, ROTATEQ. No adverse effects were reported. This is one of several reports from the same source. Additional information has been requested.
Clinic called 1/14/03 and reported that the "TD" shot she got in her arm was red and swollen down her arm, she stated that it was painful and can not lay on the arm at night. Pt was encouraged to see PMD or ER for treatment. Follow up states: Have not received forms back from reviewing medical authority.
1:20am: woke up with full body chills and felt feverish. Temperature was 99.1 4:30am: woke up with full body chills. Temperature 101.7. full body aches. headache. 6:30am: took ibuprofen.  8:00am-4pm: fever went away. aches and headache remained.  12:00pm: took ibuprofen 4pm: diarrhea 7pm: achy and lethargic. took ibuprofen 8pm: went to bed. 6:00am: woke up sweaty. Felt 99% back to normal. Left arm still sore.
Breakthrough COVID first vaccine given 3/11/2021 60 y/o fe Admitted for Abdominal Pain, Epigastric Pain, Acute Cholecystitis, Leukocytosis, Hyponatremia, Hepatomegaly, Hepatic Steatosis, and Bilateral L-5  - S1 facet Osteoarthritis.  Patient has been complaining of right upper quadrant abdominal pain ongoing for about a month.  Did have fevers and chills last night.  No melena hematochezia.  No recent traveling or sick contacts.  Patient did have episode of nausea vomiting prior to coming in.  No headache numbness or tingling.  No dizziness or lightheadedness.  Does complain of generalized weakness.  Pain is been ongoing every time she eats for about a month
Moderna 1/21/21, 2/24/21, 10/23/21. Positive on 7/15/22
Numbness and tingling of mid-back, abdomen, groin, bilateral legs and bilateral feet. Burning, pins and needles sensation of both feet. Inflammation of bilateral legs. Brain fogginess, elevated heart rate, assistance with activities of daily living. Weakness and lack of mobility in bilateral extremities.  I was given a five day course of high dose of steroids from 10/03/2020-10/08/2020 and sent to in-patient rehab 10/13/2020.
Fever started 9 hours after injection. Took Tylenol and went to bed, woke up next morning with 104 F fever (oral), took more Tylenol which brought fever down to 100.5 until 2 hours prior to being able to take next Tylenol dose. By the time it was ok to take the next dose of Tylenol, fever was back up to 103.4. This cycle persisted all day, with nausea, anorexia, muscle pain, weakness, and severe headache. Unable to take ibuprofen due to stomach intolerance. 48 hours later and the injection site is red, hot and swollen.
That noc started with arm pain, early next morning c/o general malaise requiring Tylenol, that next night severe shaking chills and increase joint pain on 6/7 no chills but continued arm stiffness and joint pain.
allergic rxn w/hives & swelling of face so far it is 10 days & still have hives;had 21 steroid pills dec DPH pills & zyrtec pills
Per pt the skin near the injection site was swollen and she felt tingling pain sensation. The adverse reaction is localized and pt has taken TYLENOL to help with pain. Instructed pt to use cold compression to help with the swollen and follow up with family doctor if no improvement.
This is a spontaneous report from a contactable physician through a Pfizer sales representative. A 60 year old female patient was administered with first dose of PREVNAR 13 in her right arm at 0.5 ml single dose on an unknown date. On the same day the patient received an influenza vaccine in her left arm. Relevant medical history was unknown. A short time after vaccination, the patient experienced significant redness in her right arm. She came back into the office the following day and showed significant swelling at the injection site. At the time of the report outcome of the above mentioned events was unknown. Follow-up (05Dec2013): Follow-up attempts completed. No further information expected.
The pedestrian accidently gave them both adult vaccine dose instead the age appropriate dose; The pedestrian accidently gave them both adult vaccine dose instead the age appropriate dose; other than pain in their arm where the vaccine is administered so far; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program (005570). The reporter is the parent.  A 7 year-old female patient received BNT162B2 (COMIRNATY), administration date 09Nov2021 (Batch/Lot number: unknown) at the age of 7 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (non-serious), ACCIDENTAL OVERDOSE (non-serious) all with onset 09Nov2021, outcome "unknown" and all described as "The pedestrian accidently gave them both adult vaccine dose instead the age appropriate dose"; PAIN IN EXTREMITY (non-serious) with onset Nov2021, outcome "unknown", described as "other than pain in their arm where the vaccine is administered so far".  Additional information: Reporter stated that my twins daughters, 7 yr, got their first Pfizer vaccine on 9th. The pedestrian accidently gave them both adult vaccine dose instead the age appropriate dose. Both my girls have develop no negative symptoms other than pain in their arm where the vaccine is administered so far. One of my twins have nephrotic syndrome. I am definitely concern for her and want to know if they should receive second dose or not. If yes what amount of dose they should get and when should be they be getting it. The caller states the report was regarding twins that are 7 years old, both received the Pfizer Covid Vaccine last Tuesday, 09Nov2021. On Friday, 12Nov2021 the caller received a call from withheld stating both patients were administered the Pfizer Covid Vaccine for older kids instead of the Pfizer Covid Vaccine 5211.  Follow-up (24Dec2021): No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
LETHARGIC; HEADACHES; FEVER; SORE AT INJECTION SITE; FEELING REALLY TIRED; TThis spontaneous report received from a patient concerned a 59 year old of unspecified sex. The patient's height, and weight were not reported. The patient's concurrent conditions included arthritis, and hypertension. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, and expiry: UNKNOWN) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On APR-2021, the subject experienced lethargic. On APR-2021, the subject experienced headaches. On APR-2021, the subject experienced fever. On APR-2021, the subject experienced sore at injection site. On APR-2021, the subject experienced feeling really tired. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the headaches, fever, lethargic, sore at injection site and feeling really tired was not reported. This report was non-serious.
Painful, swollen lymph nodes on right neck; This is a spontaneous report from a contactable Nurse. This 37-year-old female nurse reported in response to HCP letter sent in a cross-referenced case. A 37-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number: EL1283) via intramuscularly in the arm right on 14Jan2021 14:00 2nd dose, single dose for COVID-19 immunisation. Medical history included obesity BMI:37.4, hypertension taking Norvasc 5mg once daily, depression taking Wellbutrin 150 mg once daily and Xanax 0.25 mg BID, arthritis taking Vol-taren 50 mg BID, anxiety taking Wellbutrin 150 mg once daily and Xanax 0.25 mg BID, breast cancer, sarcoma. All medical history from an unknown date and unknown if ongoing, painful swol-len lymph node in left axilla from 25Dec2020 to 05Jan2021 Time: 14:00, Batch/Lot# and expira-tion date: EL0140, outcome was recovered. Concomitant medication(s) included amlodipine be-silate (NORVASC) taken for hypertension from 05Dec2019 to an unspecified stop date (hyperten-sion (5 mg PO once daily taken at night); bupropion hydrochloride (WELLBUTRIN XL) taken for depression from 03Dec2019 to an unspecified stop date (150 mg PO once daily taken in morn-ing); alprazolam (XANAX) taken for anxiety from 03Dec2019 to an unspecified stop date anxiety (0.25 mg PO BID or as needed, takes one in AM and one PM); diclofenac (VOLTAREN [DICLO-FENAC]) taken for arthritis from 03Dec2019 to an unspecified stop date (50 mg PO BID, takes one in AM and one PM). Historical vaccine includes bnt1622 (Lot Number: EL0140, Time the vac-cination was given: 14:00, arm Left: 1st Dose route of Administration: IM) COVID-19 immunisation. Prior vaccination within 4week and adverse event was none. On 14Jan2021, 14:00 the patient experienced painful swollen lymph node on right neck. Causal Relationship: Is there a reasonable possibility that the event is related to Suspect products: Yes. The clinical outcome of the event was not recovered.  No follow up attempts are possible. No further information is expected.
chills; body aches; headaches; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), MYALGIA (body aches) and HEADACHE (headaches) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced CHILLS (chills), MYALGIA (body aches) and HEADACHE (headaches). In March 2021, CHILLS (chills), MYALGIA (body aches) and HEADACHE (headaches) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was mentioned. No treatment medication was mentioned.  Patient experienced 2 days of chills, body aches, and headaches after the first vaccination.  Patient received his second Moderna COVID-19 vaccine on 2 APR 2021 lot number 019B21A.   This case was linked to MOD-2021-363368 (Patient Link).
Vaccine leaked from administration site. Could not confirm if enough vaccine was given, so we gave a new dose in the right deltoid
Pt. stated she passed out at the grocery store about 15 mins after receiving vaccine. Lost conciousness appox. 10 secs. Retured to the clinic for reporting an assessment.
Flu vaccine killed the patient/died; Initial information was received on 14-Nov-2021 regarding an unsolicited valid serious case from a consumer/non-health care professional via social media  This case involves a female patient (age unspecified) who died (death) after receiving INFLUENZA VACCINE.  It was unknown if the patient had any medical history, concomitant disease or risk factor  Medical treatment(s), vaccination(s), concomitant medications and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date the patient died (death) (unknown latency) following the administration of INFLUENZA VACCINE. This event was assessed as medically significant.  The reported stated that  Flu vaccine killed the Grandma years ago.  It was unknown if the patient experienced any additional symptoms/events  It was unknown if there were lab data/results available.  It was not reported if the patient received a corrective treatment before death  It is unknown if an autopsy was done.  Information on batch number was requested for this case; Sender's Comments: This poorly documented case from social media concerns a female patient who died after vaccination with INFLUENZA, produced by unknown manufacturer. The time to onset is unknown. Additional information regarding patient's medical history, condition at the time of vaccination, concomitant medications, lab /radiological investigation excluding other etiologies and detailed autopsy report would be needed for complete assessment of the case. Based upon the reported information, the role of vaccine cannot be assessed.; Reported Cause(s) of Death: Flu vaccine killed the patient
Headache; Swollen lymph nodes in neck; Sore throat; This is a spontaneous report from a contactable healthcare professional. A 30-year-old female patient started to receive bnt162b2 (BNT162B2; unknown lot number and expiration date), intramuscularly left arm on 23Dec2020 12:30 at single dose for COVID-19 immunization. The patient has no medical history. The patient has no known allergies. The patient was not pregnant when the vaccination was given. The patient's concomitant medications were not reported. The patient received the most recent COVID-19 vaccine in a hospital. The patient experienced headache, swollen lymph nodes in neck and sore throat on 24Dec2020 02:00 AM. The event was not considered serious, life threatening, caused/prolonged hospitalization, disabling/incapacitating or causes congenital anomaly/birth defect or death. The patient did not received treatment for the adverse event. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not have any other medications the patient received within 2 weeks of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination and has not yet been tested for COVID-19 since the vaccination. The outcome of the events was unknown.  Information on the lot/batch number has been requested